Insulet Corporation - Common Stock (NQ:PODD)

134.74 +3.05 (+2.32%)

Delayed Quote Updated: 3:39 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

26 27 Next >

PODD Stock Earnings: Insulet Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

PODD stock results show that Insulet missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year

August 08, 2024

From Insulet Corporation

Via Business Wire

Wall Street Set For Uneventful Start Ahead Of Jobless Claim Data, VIX Rises: Strategist Says Market May Remain Vulnerable Until... ↗

August 08, 2024

U.S. stocks are set for a mixed start on Thursday as concerns regarding the economy and incremental yen carry trade unwinding remain an undercurrent. Traders may be keen to receive the jobless claims...

Via Benzinga

Topics Economy Stocks

Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

August 08, 2024

INSULET CORP (NASDAQ:PODD)—A High-Growth Stock Gearing Up for Its Next Upward Move.

Via Chartmill

Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today ↗

August 07, 2024

Via Benzinga

Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday? ↗

August 08, 2024

Investor risk sentiment is showing greater conviction on Thursday, with all indices and major stock sectors in the green, after Wall Street failed to hold onto opening gains and closed in the red the...

Via Benzinga

Chips, Glorious Chips! ↗

August 07, 2024

Someone's gotta make 'em, and someone's gotta buy 'em.

Via The Motley Fool

A Closer Look at 7 Analyst Recommendations For Insulet ↗

July 23, 2024

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $26,000 Today ↗

July 19, 2024

Via Benzinga

Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout. ↗

July 17, 2024

Why INSULET CORP (NASDAQ:PODD) Is a Standout High-Growth Stock in a Consolidation Phase.

Via Chartmill

Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today? ↗

July 26, 2024

Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook.

Via Benzinga

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

July 26, 2024

From Insulet Corporation

Via Business Wire

Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

July 10, 2024

Via Benzinga

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

July 08, 2024

From Insulet Corporation

Via Business Wire

(PODD) - Analyzing Insulet's Short Interest ↗

July 05, 2024

Via Benzinga

Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

June 26, 2024

INSULET CORP (NASDAQ:PODD), a strong growth stock, setting up for a breakout.

Via Chartmill

$1000 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗

June 21, 2024

Via Benzinga

Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

June 21, 2024

From Insulet Corporation

Via Business Wire

Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

June 20, 2024

From Insulet Corporation

Via Business Wire

Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

June 20, 2024

From Insulet Corporation

Via Business Wire

Looking Into Insulet's Recent Short Interest ↗

June 17, 2024

Via Benzinga

Where Insulet Stands With Analysts ↗

May 30, 2024

Via Benzinga

The 3 Best Diabetes Stocks to Buy in June 2024 ↗

June 19, 2024

There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy.

Via InvestorPlace

7 Stocks That Could Safely 10X by 2030 ↗

June 06, 2024

Unlock the potential for exponential growth with these seven 10x stocks that could skyrocket by 2030 if the stars align.

Via InvestorPlace

Insulet to Present at the Jefferies Global Healthcare Conference

May 28, 2024

From Insulet Corporation

Via Business Wire

NASDAQ:PODD, a strong growth stock, setting up for a breakout. ↗

May 21, 2024

INSULET CORP (NASDAQ:PODD), a strong growth stock, setting up for a breakout.

Via Chartmill

Is NASDAQ:PODD suited for growth investing? ↗

May 20, 2024

INSULET CORP (NASDAQ:PODD) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio? ↗

May 19, 2024

Top performing large-cap stocks in the last week: MSTR, MNDY, ONON, SE, PODD, DELL, VOD, ALC, SMCI, CRBG. Analysts raise price targets & more positive news.

Via Benzinga

Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains ↗

May 19, 2024

Ride the coattails of institutional investors with these three overlooked stocks smart money investors are piling into for triple-digit gains.

Via InvestorPlace

Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market ↗

May 14, 2024

Latest on Insulet and its legal battle with EOFlow. Understand the impact of the appellate court's decision on market dynamics and Insulet's future.

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

26 27 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.